Cargando…

Study to increase the pneumococcal vaccination rates of individuals aged 65 years and older

BACKGROUND: In our study, we intended to observe the impact of recommending the pneumococcal vaccine to individuals who were called on the phone or interviewed face-to-face by their doctors on vaccination rates. METHODS: Two hundred individuals who were 65 years old and older were included in our st...

Descripción completa

Detalles Bibliográficos
Autores principales: Biyik, M. V., Arslan, I., Yengil Taci, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576541/
https://www.ncbi.nlm.nih.gov/pubmed/32985407
http://dx.doi.org/10.1017/S1463423620000389
_version_ 1783598036158513152
author Biyik, M. V.
Arslan, I.
Yengil Taci, D.
author_facet Biyik, M. V.
Arslan, I.
Yengil Taci, D.
author_sort Biyik, M. V.
collection PubMed
description BACKGROUND: In our study, we intended to observe the impact of recommending the pneumococcal vaccine to individuals who were called on the phone or interviewed face-to-face by their doctors on vaccination rates. METHODS: Two hundred individuals who were 65 years old and older were included in our study. They were questioned about their awareness regarding adult immunisation, and their knowledge level and vaccination statuses were determined regarding the tetanus, influenza, hepatitis, and pneumococcal vaccines. After they were given information about the pneumococcal vaccine, they were asked about their interest in being vaccinated. Those who agreed to be vaccinated were invited and vaccinated. RESULTS: According to the questionnaire, 150 people (75%) knew of the influenza vaccine, 130 people (65%) knew of the tetanus vaccine, 53 people (26.5%) knew of the hepatitis B vaccine, and 49 people (24.5%) knew of the pneumococcal vaccine. A total of five people (2.5%) had received the pneumococcal vaccine. Fifty-eight of 97 patients (59.8%) who completed the questionnaire during a phone call and 84 of 103 patients (81.6%) who completed the questionnaire during a face-to-face interview received the pneumococcal vaccine. As a result, the rates of pneumococcal vaccination increased from 2.5% before the study to 73.5% after the study. CONCLUSION: The findings show that the vaccination rates for pneumococcus were very low among our participants. The immunisation rates increased when doctors provided consultation to participants about adult immunisation.
format Online
Article
Text
id pubmed-7576541
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-75765412020-10-29 Study to increase the pneumococcal vaccination rates of individuals aged 65 years and older Biyik, M. V. Arslan, I. Yengil Taci, D. Prim Health Care Res Dev Research BACKGROUND: In our study, we intended to observe the impact of recommending the pneumococcal vaccine to individuals who were called on the phone or interviewed face-to-face by their doctors on vaccination rates. METHODS: Two hundred individuals who were 65 years old and older were included in our study. They were questioned about their awareness regarding adult immunisation, and their knowledge level and vaccination statuses were determined regarding the tetanus, influenza, hepatitis, and pneumococcal vaccines. After they were given information about the pneumococcal vaccine, they were asked about their interest in being vaccinated. Those who agreed to be vaccinated were invited and vaccinated. RESULTS: According to the questionnaire, 150 people (75%) knew of the influenza vaccine, 130 people (65%) knew of the tetanus vaccine, 53 people (26.5%) knew of the hepatitis B vaccine, and 49 people (24.5%) knew of the pneumococcal vaccine. A total of five people (2.5%) had received the pneumococcal vaccine. Fifty-eight of 97 patients (59.8%) who completed the questionnaire during a phone call and 84 of 103 patients (81.6%) who completed the questionnaire during a face-to-face interview received the pneumococcal vaccine. As a result, the rates of pneumococcal vaccination increased from 2.5% before the study to 73.5% after the study. CONCLUSION: The findings show that the vaccination rates for pneumococcus were very low among our participants. The immunisation rates increased when doctors provided consultation to participants about adult immunisation. Cambridge University Press 2020-09-28 /pmc/articles/PMC7576541/ /pubmed/32985407 http://dx.doi.org/10.1017/S1463423620000389 Text en © Cambridge University Press 2020 http://creativecommons.org/licenses/by/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Biyik, M. V.
Arslan, I.
Yengil Taci, D.
Study to increase the pneumococcal vaccination rates of individuals aged 65 years and older
title Study to increase the pneumococcal vaccination rates of individuals aged 65 years and older
title_full Study to increase the pneumococcal vaccination rates of individuals aged 65 years and older
title_fullStr Study to increase the pneumococcal vaccination rates of individuals aged 65 years and older
title_full_unstemmed Study to increase the pneumococcal vaccination rates of individuals aged 65 years and older
title_short Study to increase the pneumococcal vaccination rates of individuals aged 65 years and older
title_sort study to increase the pneumococcal vaccination rates of individuals aged 65 years and older
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576541/
https://www.ncbi.nlm.nih.gov/pubmed/32985407
http://dx.doi.org/10.1017/S1463423620000389
work_keys_str_mv AT biyikmv studytoincreasethepneumococcalvaccinationratesofindividualsaged65yearsandolder
AT arslani studytoincreasethepneumococcalvaccinationratesofindividualsaged65yearsandolder
AT yengiltacid studytoincreasethepneumococcalvaccinationratesofindividualsaged65yearsandolder